WO2023052808 - GEL CONTAINING DUAL L-CARNOSINE/ALOE VERA NANOPHYTOSOMES FOR ACCELERATING DIABETIC WOUND HEALING
National phase entry is expected:
Publication Number
WO/2023/052808
Publication Date
06.04.2023
International Application No.
PCT/IB2021/058812
International Filing Date
28.09.2021
Title **
[English]
GEL CONTAINING DUAL L-CARNOSINE/ALOE VERA NANOPHYTOSOMES FOR ACCELERATING DIABETIC WOUND HEALING
[French]
GEL CONTENANT DES NANOPHYTOSOMES DOUBLES DE L-CARNOSINE/ALOE VERA POUR ACCÉLÉRER LA CICATRISATION DES PLAIES DIABÉTIQUES
Applicants **
DARVISHI, Behrad
39th avenue, Sayed Jamaluddin Square, Yusef Abad,
Tehran, 1434674651, IR
Inventors
AGHAMIRI, Helia
Kaveh Street, Aghaei Street, Farmanieh Street,
Tehran, IR
SHARIFI, Ali Mohammad
Dowlat Street, Shariati Street
Tehran, IR
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
IP India
* |
| Applicant's Legal Status |
Natural Person
* |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 899 | |
| EPO | Filing, Examination | 5342 | |
| Japan | Filing | 589 | |
| South Korea | Filing | 482 | |
| USA | Filing, Examination | 2710 |
Total: 10022 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
whole leaf extract and L-Carnosine in management of different types of wound, especially the ones associates with diabetes by providing anti-inflammatory, soothing, antimicrobial, analgesic, proangiogenic effects and cyto-protective activity on proliferative cells in the wound site.[French]
et de la L-carnosine dans la prise en charge de différents types de plaie, en particulier ceux associées au diabète en présentant des activités anti-inflammatoires, apaisantes, antimicrobiennes, analgésiques, pro-angiogéniques et cytoprotectrices sur des cellules prolifératives dans le site de la plaie.